The role of nutritional deficiency in the osteopenia and osteoporosis of gastrointestinal diseases

Current Opinion in Gastroenterology

Volumn 18, Issue 2, 2002, Pages 203-208

  Alpers, David H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; SELECTIVE ESTROGEN RECEPTOR MODULATOR; VITAMIN D;

BONE DENSITY; BONE MINERAL; CELIAC DISEASE; CROHN DISEASE; GASTROINTESTINAL DISEASE; GENETIC ANALYSIS; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; NUTRITIONAL DEFICIENCY; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; REVIEW;

EID: 0036201655     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200203000-00009     Document Type: Review

References (49)

1. The osteoblast: A sophisticated fibroblast under central surveillance
2. Bone resorption by osteoclast
3. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
4. Vitamin D deficiency and bone disease in patients with Crohn's disease
5. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease
6. Reduced bone density in patients with inflammatory bowel disease
7. Decreased bone mineral density after therapy with alpha interferon in combination with ribavirin for chronic hepatitis C
8. Osteopenia assessed by body composition analysis is related to malnutrition in alcoholic patients
9. Role of genetic factors in the pathophysiology and management of osteoporosis
10. The association of bone mineral density with vitamin D receptor gene polymorphisms
11. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women
12. Corticosteroid-induced bone loss: Prevention and management
13. Low serum and bone vitamin K status in patients with longstanding Crohn's disease: Another pathogenetic factor of osteoporosis in Crohn's disease?
14. Different approaches to bone densitometry
15. Sex difference in the validity of vertebral deformities as an index of prevalent vertebral osteoporotic fractures: A population survey of older men and women
16. Population-based geographic variations in DXA bone density in Europe: The EVOS Study, European Vertebral Osteoporosis
17. Study of incidence of osteoporotic fractures in a cohort of individuals older than 50 years from Asturias, Spain, after a 6 year follow-up period
18. The comorbid occurrence of other diagnoses in patients with ulcerative colitis and Crohn's disease
19. Inflammatory bowel disease and osteoporosis
20. Guidelines for osteoporosis in celiac disease and inflammatory bowel disease
21. Bone mineral density in patients with recently diagnosed inflammatory bowel disease
22. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis
23. Altered bone metabolism in inflammatory bowel disease: There is a difference between Crohn's disease and ulcerative colitis
24. Osteopenia and osteoporosis in Crohn's disease: Prevalence in a Dutch population-based cohort
25. Osteoporosis and determinants of bone density in patients with Crohn's disease
26. The incidence of fracture among patients with inflammatory bowel disease
27. Vertebral compression fractures in pediatric patients with Crohn's disease
28. Risk of fractures in celiac disease patients: A cross-sectional, case-control study
29. Pre- and post-treatment serum levels of cytokines IL-1β, IL-6, and IL-1 receptor antagonist in celiac disease: Are they related to the associated osteopenia?
30. Hepatic osteodystrophy
31. Bone disease in cholestatic liver disease
32. Bone density and metabolism in patients with viral hepatitis and cholestatic liver disease before and after liver transplantation
33. Calcitriol for bone loss in patients with primary biliary cirrhosis
34. Bone mass in women with primary biliary cirrhosis: The relation with histological stage and use of glucocorticoids
35. Osteoporosis in primary biliary cirrhosis revisited
36. A prospective study on the effect of recipient nutritional status on outcome of liver transplantation
37. A prospective randomized study of preoperative nutritional supplementation in patients awaiting elective orthotopic liver transplantation
38. Incidence of vertebral fractures in the first three months after orthotopic liver transplantation
39. American College of Rheumatology Task Force on Osteoporosis Guidelines. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
40. Correcting calcium nutritional deficiency prevents spine fractures in elderly women
41. Calcium and vitamin D supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis
42. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis (Cochrane Review)
43. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial
44. Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease
45. Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study
46. Etidronate for osteoporosis in primary biliary cirrhosis: A randomized trial
47. Intravenous biphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation
48. A U.K. consensus group of management of corticosteroid-induced osteoporosis: An update
49. Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease